Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-224965
Filing Date
2023-08-30
Accepted
2023-08-30 16:31:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d496327ddefa14a.htm DEFA14A 19219
2 GRAPHIC g496327g03g03.jpg GRAPHIC 456767
3 GRAPHIC g496327g04g04.jpg GRAPHIC 867834
  Complete submission text file 0001193125-23-224965.txt   1845157
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36066 | Film No.: 231225643
SIC: 2834 Pharmaceutical Preparations